459
Participants
Start Date
March 31, 2012
Primary Completion Date
September 30, 2015
Study Completion Date
October 31, 2015
Fluticasone/Salmeterol Diskus
Continuation of Fluticasone/Salmeterol Diskus 250/50 ug twice daily
Fluticasone/Salmeterol Diskus
Reduced dose Fluticasone/Salmeterol Diskus 100/50 ug twice daily
Fluticasone Diskus
Fluticasone Diskus alone 250 ug twice daily without Salmeterol
New York University School of Medicine, New York
Maria Fareri Children's Hospital at Westchester Medical Center and New York Medical College, Valhalla
Hofstra North Shore-LIJ School of Medicine, New Hyde Park
University of Virginia, Charlottesville
Duke University Medical Center, Durham
Nemours Children's Clinic, Jacksonville
University of Miami/University of South Florida, Tampa
The Ohio State University Medical Center, Columbus
St. Vincent Healthcare, Indianapolis
St. Vincent Hospital and Health Care Center, Inc, Indianapolis
The Illinois Consortium, Chicago
Washington University/St. Louis University, St Louis
University of Missouri, Kansas City School of Medicine, Kansas City
Louisiana State University Health Sciences Center, The Ernest N. Morial Asthma, Allergy and Respiratory Disease Center, New Orleans
Baylor College of Medicine, Houston
National Jewish Health, Denver
University of Arizona, Arizona Respiratory Center, Tucson
University of California, San Diego, San Diego
Northern New England Consortium, Colchester
Collaborators (1)
American Lung Association
OTHER
GlaxoSmithKline
INDUSTRY
Johns Hopkins University
OTHER